About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

MK3207 for Treatment of Acute Migraines (3207-005) | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00712725

MK3207 for Treatment of Acute Migraines (3207-005)

The purpose of the study is to demonstrate the effectiveness and appropriate dosage level of MK3207 in the treatment of acute migraine.

Lead sponsor: Merck Sharp & Dohme LLC•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Merck Sharp & Dohme LLC

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Men and Women from 18 to 65 years of age
•1+ year history of migraine that typically last from 4 to 72 hours if untreated
•Had from 2 to 8 moderate or severe migraine attacks per month in the last 2 months
•Not pregnant or planning to become pregnant in next 6 months

Exclusion Criteria

•Pregnant or breast-feeding, or planning to become pregnant in next 6 months
•Cannot distinguish migraine attacks from tension type headaches
•Migraines are mild or resolve without medication in less than 2 hours
•More than 15 headache-days per month or have taken medication on more than 10 days per month in the last 3 months
•Basilar type or hemiplegic migraine headaches
•More than 50 years old when migraines began
•History of cardiovascular disorder within last 6 months

Related studies

Chiropractic Care for Episodic Migraine

NCT06229834 · Episodic Migraine

Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD

NCT07348783 · Cluster Headache - Episodic and Chronic, Migraine Headache, and more

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

NCT06603558 · Chronic Migraine, Episodic Migraine, and more

BE WELL With Migraine: Brain Education and WELLness With Migraine

NCT05987592 · Migraine

i-NEED: NEw migrainE Drugs Database

NCT07103694 · Episodic Migraine, Chronic Migraine, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 2, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment676

Start dateJul 2008

Last updatedFeb 2, 2015

Condition

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2015Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions